ABBV
Price
$208.82
Change
+$0.90 (+0.43%)
Updated
Aug 29, 11:28 AM (EDT)
Capitalization
367.3B
56 days until earnings call
ALPMF
Price
$11.48
Change
+$0.38 (+3.42%)
Updated
Aug 19 closing price
Capitalization
19.67B
Interact to see
Advertisement

ABBV vs ALPMF

Header iconABBV vs ALPMF Comparison
Open Charts ABBV vs ALPMFBanner chart's image
ABBVIE
Price$208.82
Change+$0.90 (+0.43%)
Volume$550
Capitalization367.3B
Astellas Pharma
Price$11.48
Change+$0.38 (+3.42%)
Volume$1.07K
Capitalization19.67B
ABBV vs ALPMF Comparison Chart in %
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. ALPMF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a StrongBuy and ALPMF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ABBV: $207.92 vs. ALPMF: $11.48)
Brand notoriety: ABBV: Notable vs. ALPMF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 82% vs. ALPMF: 106%
Market capitalization -- ABBV: $367.3B vs. ALPMF: $19.67B
ABBV [@Pharmaceuticals: Major] is valued at $367.3B. ALPMF’s [@Pharmaceuticals: Major] market capitalization is $19.67B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 2 FA rating(s) are green whileALPMF’s FA Score has 1 green FA rating(s).

  • ABBV’s FA Score: 2 green, 3 red.
  • ALPMF’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABBV and ALPMF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while ALPMF’s TA Score has 4 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 4 bearish.
  • ALPMF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than ALPMF.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а -0.75% price change this week, while ALPMF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.92%. For the same industry, the average monthly price growth was +1.19%, and the average quarterly price growth was +11.79%.

Reported Earning Dates

ABBV is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.92% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($367B) has a higher market cap than ALPMF($19.7B). ABBV has higher P/E ratio than ALPMF: ABBV (99.01) vs ALPMF (59.95). ABBV YTD gains are higher at: 20.231 vs. ALPMF (16.430). ALPMF has higher annual earnings (EBITDA): 270B vs. ABBV (14.2B). ALPMF has more cash in the bank: 329B vs. ABBV (6.47B). ABBV has less debt than ALPMF: ABBV (70.5B) vs ALPMF (927B). ALPMF has higher revenues than ABBV: ALPMF (1.77T) vs ABBV (58.3B).
ABBVALPMFABBV / ALPMF
Capitalization367B19.7B1,863%
EBITDA14.2B270B5%
Gain YTD20.23116.430123%
P/E Ratio99.0159.95165%
Revenue58.3B1.77T3%
Total Cash6.47B329B2%
Total Debt70.5B927B8%
FUNDAMENTALS RATINGS
ABBV vs ALPMF: Fundamental Ratings
ABBV
ALPMF
OUTLOOK RATING
1..100
1849
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
11100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
2443
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMF's Valuation (8) in the null industry is significantly better than the same rating for ABBV (89) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew significantly faster than ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (11) in the Pharmaceuticals Major industry is significantly better than the same rating for ALPMF (100) in the null industry. This means that ABBV’s stock grew significantly faster than ALPMF’s over the last 12 months.

ABBV's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as ALPMF (100) in the null industry. This means that ABBV’s stock grew similarly to ALPMF’s over the last 12 months.

ABBV's Price Growth Rating (24) in the Pharmaceuticals Major industry is in the same range as ALPMF (43) in the null industry. This means that ABBV’s stock grew similarly to ALPMF’s over the last 12 months.

ABBV's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as ALPMF (100) in the null industry. This means that ABBV’s stock grew similarly to ALPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVALPMF
RSI
ODDS (%)
Bearish Trend 1 day ago
42%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
52%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
48%
Advances
ODDS (%)
Bullish Trend 8 days ago
57%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
44%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
38%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ROAM27.140.21
+0.77%
Hartford Multifactor Emerging Mkts ETF
GWX39.360.27
+0.69%
SPDR® S&P® International Small Cap ETF
DBAW38.390.06
+0.16%
Xtrackers MSCI All World exUS Hdg Eq ETF
USMV94.03-0.03
-0.03%
iShares MSCI USA Min Vol Factor ETF
REKT18.11-0.07
-0.37%
Direxion Daily Crypto Industry Bear1XETF

ALPMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMF
1D Price
Change %
ALPMF100%
N/A
ALPMY - ALPMF
38%
Loosely correlated
+0.82%
JNJ - ALPMF
13%
Poorly correlated
-0.76%
GRFS - ALPMF
10%
Poorly correlated
+0.71%
AZNCF - ALPMF
8%
Poorly correlated
-1.53%
ABBV - ALPMF
5%
Poorly correlated
-0.07%
More